Artificial Intelligence Seen as a Potential Aid to Bridge Gaps in Women's Health Services
Recent industry analysis indicates that artificial intelligence technology shows potential in improv...
Indigenization of China's High-End Medical Equipment: CGN Develops Proton Therapy System
CGN's "Hezhi®" Proton Therapy System was featured in the "Building the Foundation f...
Establishment of Cell Therapy Center at Guangdong Second Provincial General Hospital in China Promotes Precision Treatment for Hematologic Diseases
Recently, the Cell Therapy Center of the Hematology Department at Guangdong Second Provincial Genera...
Biopharmaceutical Company Mendra Completes $82 Million Series A Funding to Accelerate Rare Disease Treatment R&D
Mendra, a biopharmaceutical company headquartered in San Francisco, USA, recently announced its offi...
Aqneursa Approved by EU for Neurological Treatment
IntraBio, a biopharmaceutical company based in Texas, USA, recently announced that its drug Aqneursa...
Intuitive Surgical Exceeds Expectations in Q4 2025 Performance
The global surgical robot manufacturer Intuitive Surgical recently released its Q4 2025 earnings rep...
Infinitopes Completes Second Seed Funding Round to Accelerate Esophageal Cancer Vaccine Clinical Trial
UK-based cancer vaccine biotechnology company Infinitopes recently announced the successful completi...
Novavax Enters into Significant Licensing Agreement with Pfizer
Shares of the American biotechnology company Novavax rose 9% to $8.72 as of January 20. This increas...
Ipsen's IPN60340 Receives FDA Breakthrough Therapy Designation for Acute Myeloid Leukemia
The U.S. Food and Drug Administration (FDA) recently granted Breakthrough Therapy Designation (BTD) ...
ImmunityBio Receives Saudi Approval for Anktiva's New Therapy in Lung Cancer Treatment
New developments have emerged from the American immunotherapy company ImmunityBio. The Saudi Food an...